Study Stopped
Key Personnel Left Institution Prior to Study Completion
The Role of Cerebral Oximetry in Pediatric Concussion Assessment
1 other identifier
observational
59
1 country
1
Brief Summary
The purpose of this study is to determine whether there is a difference in cerebral oxygenation as measured by near-infrared spectroscopy (NIRS) in children with concussion and healthy controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
January 13, 2014
CompletedFirst Posted
Study publicly available on registry
January 15, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2015
CompletedFebruary 5, 2018
January 1, 2018
1.5 years
January 13, 2014
January 31, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in mean baseline regional cerebral oxygen saturation as measured by near-infrared spectroscopy between children with mild traumatic brain injury and controls.
At presentation (Day 0)
Secondary Outcomes (2)
Difference in the change in regional cerebral oxygen saturation during handgrip exercise between children with mild traumatic brain injury and controls.
At presentation (Day 0)
Difference in Sport Concussion Assessment Tool 2 (SCAT2) total score between patients with mild traumatic brain injury and controls.
At presentation (Day 0)
Study Arms (2)
Concussion Group
Control Group
Eligibility Criteria
This pilot study will employ a prospective cohort study design. Children aged 10-18 years will be recruited within the Johns Hopkins Hospital Pediatric Emergency Department (JHH PED) to participate in this study. All children must be conversant in English.
You may qualify if:
- All Participants
- Age 10-18 years at time of visit
- Concussion Group
- Present to JHH PED within the first 24 hours following trauma.
- Diagnosis of concussion as defined by the 3rd International Conference on Concussion in Sport (McCrory), including the presence of any one or more of the following:
- Symptoms (ie. headache, neck pain, nausea/vomiting, dizziness, blurred vision, balance problems, sensitive to light, sensitivity to noise, feeling slowed down, feeling in a fog, difficulty concentrating, difficulty remembering, fatigue, confusion, drowsiness, more emotional, irritability, sadness, nervous)
- Physical Signs (ie. loss of consciousness, unsteadiness)
- Impaired brain function (ie. confusion)
- Glasgow Coma Score of 13-15 upon arrival to JHH PED.
- Loss of consciousness of less than 15 minutes (if applicable).
- No structural intracranial injuries identified on neuroimaging (if completed).
You may not qualify if:
- All Participants
- History of prior concussion or traumatic brain injury within preceding 6 weeks.
- History of prior intracranial disease or mass (ie. tumor, intraventricular hemorrhage, etc.)
- Presence of intracranial hardware.
- Complaints of respiratory distress, tachypnea or hypoxia, which may affect regional cerebral oxygen saturation.
- Inability to stand secondary to lower extremity disease or trauma, which is required for completion of SCAT2.
- Inability to complete SCAT2 questionnaire secondary to developmental delay.
- Child in foster care or legal guardian not available.
- Participant known to be pregnant, which alters total body blood flow and likely affects regional cerebral oxygen saturation.
- Non-English speaking.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Johns Hopkins Universitylead
- Medtronic - MITGcollaborator
Study Sites (1)
Johns Hopkins University Pediatric Emergency Medicine
Baltimore, Maryland, 21224, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Anders, MD
Johns Hopkins University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 13, 2014
First Posted
January 15, 2014
Study Start
January 1, 2014
Primary Completion
June 30, 2015
Study Completion
June 30, 2015
Last Updated
February 5, 2018
Record last verified: 2018-01